英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
VIP(6-28)(human, rat, porcine, bovine)
|
69698-54-0 |
PHE-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2
|
|
C126H207 N37 O34 S |
2816.28 | |
VAPREOTIDE
|
103222-11-3 |
伐普肽
|
伐普肽,BR;伐普肽;VAPREOTIDE ACETATE 伐普肽及杂质对照品;醋酸伐普肽;醋酸伐普肽 103222-11-4
|
C57H70N12O9S2 |
1131.37 | |
UROTENSIN II (HUMAN)
|
251293-28-4 |
GLU-THR-PRO-ASP-CYS-PHE-TRP-LYS-TYR-CYS-VAL(DISULFIDE BRIDGE:CYS5-CYS1)
|
|
C64H87N13O18S2 |
1390.58 | |
Urocortin (rat)
|
171543-83-2 |
ASP-ASP-PRO-PRO-LEU-SER-ILE-ASP-LEU-THR-PHE-HIS-LEU-LEU-ARG-THR-LEU-LEU-GLU-LEU-ALA-ARG-THR-GLN-SER-GLN-ARG-GLU-ARG-ALA-GLU-GLN-ASN-ARG-ILE-ILE-PHE-ASP-SER-VAL
|
尾促皮质肽;优洛可定;UROCORTIN RAT,≥97% ;ASP-ASP-PRO-PRO-LEU-SER-ILE-ASP-LEU-THR-PHE-HIS-LEU-LEU-ARG-THR-LEU-LEU-GLU-LEU-ALA-ARG-THR-GLN-SER-GLN-ARG-GLU-ARG-ALA-GLU-GLN-ASN-ARG-ILE-ILE-PHE-ASP-SER-VAL;ASP-ASP-PRO-PRO-LEU-SER-ILE-ASP-LEU-THR-PHE-HIS-LEU-LEU-ARG-THR-LEU-LEU-GLU-LEU-ALA-ARG-THR-GLN-SER-GLN-ARG-GLU-ARG-ALA-GLU-GLN-ASN-ARG-ILE-ILE-PHE-ASP-SER-VAL-NH2
|
C206H338N62O64 |
4707.26492 | |
Urocortin (human)
|
176591-49-4 |
ASP-ASN-PRO-SER-LEU-SER-ILE-ASP-LEU-THR-PHE-HIS-LEU-LEU-ARG-THR-LEU-LEU-GLU-LEU-ALA-ARG-THR-GLN-SER-GLN-ARG-GLU-ARG-ALA-GLU-GLN-ASN-ARG-ILE-ILE-PHE-ASP-SER-VAL-NH2
|
ASP-ASN-PRO-SER-LEU-SER-ILE-ASP-LEU-THR-PHE-HIS-LEU-LEU-ARG-THR-LEU-LEU-GLU-LEU-ALA-ARG-THR-GLN-SER-GLN-ARG-GLU-ARG-ALA-GLU-GLN-ASN-ARG-ILE-ILE-PHE-ASP-SER-VAL-NH2;新型血管活性因子 ≥85% (-20°C);UROCORTIN HUMAN,≥85% ;尾促皮质肽 I
|
C206H338F3N63O66 |
4810.26563 | |
Urocortin II, human
|
398001-88-2 |
ILE-VAL-LEU-SER-LEU-ASP-VAL-PRO-ILE-GLY-LEU-LEU-GLN-ILE-LEU-LEU-GLU-GLN-ALA-ARG-ALA-ARG-ALA-ALA-ARG-GLU-GLN-ALA-THR-THR-ASN-ALA-ARG-ILE-LEU-ALA-ARG-VAL-GLY-HIS-CYS-NH2
|
|
C196H340F3N63O56S |
4564.24551 | |
URECHISTACHYKININ II
|
149097-04-1 |
ALA-ALA-GLY-MET-GLY-PHE-PHE-GLY-ALA-ARG-NH2
|
AAGMGFFGAR-NH2;ALA-ALA-GLY-MET-GLY-PHE-PHE-GLY-ALA-ARG-NH2;H-ALA-ALA-GLY-MET-GLY-PHE-PHE-GLY-ALA-ARG-NH2;URECHISTACHYKININ II;URU-TK II
|
C44H66N14O10S |
||
Triptorelin Acetate
|
140194-24-7 |
醋酸曲普瑞林
|
醋酸曲普瑞林,曲普瑞林
|
C64H82N18O13.C2H4O2 |
1371.52 | |
L-Proline,glycyl-L-prolyl-4-hydroxy-, (4R)-
|
2239-67-0 |
H-GLY-PRO-HYP-OH
|
甘氨酸-脯氨酸-羟脯氨酸;三肽-29;胶原三肽;胶原三肽;胶原三肽原料;胶原三肽制药用;胶原三肽;胶原三肽
|
C12H19N3O5 |
285.3 | |
Trifluoroacetyl Tripeptide-2
|
64577-63-5 |
TFA-VAL-TYR-VAL-OH
|
三氟乙酰基三肽-2
|
C21H28F3N3O6 |
475.46 | |
H-SER-PHE-LEU-LEU-ARG-ASN-PRO-OH
|
145229-76-1 |
SER-PHE-LEU-LEU-ARG-ASN-PRO
|
|
C39H63N11O10 |
845.99 | |
FLLRN
|
141136-84-7 |
PHE-LEU-LEU-ARG-ASN
|
|
C31H51N9O7 |
661.79 | |
Taltirelin
|
103300-74-9 |
他替瑞林
|
(4S)-N-[(2S)-1-[(2S)-2-氨基甲酰基吡咯烷-1-基]-3-(3H-咪唑-4-基)-1-氧代丙-2-基]-1-甲基-2,6-二氧代-1,3-二氮杂己环-4-甲酰胺;他替瑞林;醋酸他替瑞林;1-METHYL-4,5-DIHYDROOROTYL-HIS-PRO-NH2
|
C17H23N7O5 |
405.41 | |
thymalfasin
|
62304-98-7 |
胸腺肽 alpha 1
|
胸腺28肽;胸腺阿尔法一;胸腺肽A-1;胸腺肽Α1(THYMOSINΑ1);AC-SER-ASP-ALA-ALA-VAL-ASP-THR-SER-SER-GLU-ILE-THR-THR-LYS-ASP-LEU-LYS-GLU-LYS-LYS-GLU-VAL-VAL-GLU-GLU-ALA-GLU-ASN: AC-SDAAVDTSSEITTKDLKEKKEVVEEAEN;胸腺肽Α1 62304-98-7;胸腺肽(小牛);醋酸胸腺肽α2
|
C129H215N33O55 |
3108.28 | 1592732-453-0 |
Trandolapril
|
87679-37-6 |
群多普利
|
群多普利-D5;群多普利溶液,1000PPM;(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-乙氧基甲酰-3-苯基-丙基]氨基]丙酰基]-2,3,3a,4,5,6,7,7a-八氢吲哚-2-甲酸;群多普利;群多普利溶液,101PPM;喘乐普利;小精灵杂质;佐匹克隆氧化物
|
C24H34N2O5 |
430.54 | 618-046-0 |
Topotecan Hydrochloride
|
119413-54-6 |
盐酸拓扑替康
|
(S)-10-[(二甲基氨基)甲基]-4-乙基-4,9-二羟基-1H-吡喃并[3',4':6,7]氮茚并[1,2-b]-喹啉-3-14(4H,12H)-二酮盐酸盐;盐酸拓扑替康;盐酸拓普替康(替康类);拓扑替康(盐酸);拓扑替康盐酸盐(标准品);TOPOTECAN HYDROCHLORIDE 盐酸拓扑替康;盐酸拓普替康;拓普替康
|
C23H23N3O5.HCl |
457.90676 | 601-607-9 |
Thymosin beta 4 acetate
|
77591-33-4 |
胸腺素 beta 4
|
胸腺素 beta 4;醋酸胸腺肽β4;胸腺素Β4;胸腺肽Β4;胸腺素Β4 THYMOSINΒ4ACETATE;醋酸胸腺肽素Β4;胸腺肽Β4>98%;醋酸胸腺Β4
|
C212H350N56O78S |
4963.4408 | 1592732-453-0 |
Thymopentin
|
69558-55-0 |
胸腺五肽
|
胸腺喷丁;胸腺生成素;THYMOPENTIN肽;胸腺五肽 69558-55-0;胸腺五肽 THYMOPENTIN;胸腺五肽,98%;刹莫潘汀;西布新曲明
|
C30H49N9O9 |
679.8 | 811-641-8 |
H-SER-PHE-LEU-LEU-ARG-OH
|
141685-53-2 |
SER-PHE-LEU-LEU-ARG
|
|
C30H50N8O7 |
634.77 | |
TFLLR-NH2(TFA)
|
1313730-19-6 |
131373-19-6
|
TFLLR-NH2(TFA);197794-83-5 (Thr1)-TRAP-5 amide
|